Inotiv (NOTV)
(Delayed Data from NSDQ)
$1.83 USD
+0.13 (7.65%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $1.84 +0.01 (0.55%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth F Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 37% (93 out of 252)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.67 | 1.56 | 9.99 |
Current Quarter Estimate | 0.00 | 0.26 | 63.00 |
Year Ago Quarter Estimate | -0.29 | -0.05 | 52.25 |
Next Quarter Estimate | NA | -1.84 | 66.00 |
Next Year Estimate | 0.04 | 12.89 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 79.67 | 20.10 | NA |
Next Year | 110.81 | 16.80 | NA |
Last 5 Years | NA | 7.80 | 8.10 |
Next 5 Years | NA | 21.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -2.09 |
Price/Book (MRQ) | 0.26 | 1.51 |
Price/Cash Flow (MRFY) | 4.24 | 8.65 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -19.80% | -56.43% |
Return on Equity (TTM) | -15.55% | -58.58% |
Debt to Equity (MRQ) | NA | 0.00 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.